Central Vertigo (n = 23) | Peripheral Vertigo (n = 35) | P value | |
---|---|---|---|
Age, years, mean (SD) | 64.52 (11.80) | 63.69 (9.42) | 0.766 |
Female, % (n) | 21.7% (5) | 82.9% (29) | 0.001* |
Body mass index, kg/m2, mean (SD) | 24.89 (3.96) | 24.56 (4.62) | 0.59 |
Onset to blood collection (hrs), mean (SD) | 37.59 (16.94) | 21.35 (17.91) | 0.001* |
Stroke risk factors, % (n) | |||
- Hypertension | 65.2% (15) | 51.4% (18) | 0.30 |
- Diabetes mellitus | 52.2% (12) | 17.1% (6) | 0.005* |
- Dyslipidemia | 56.5% (13) | 48.6% (17) | 0.55 |
- History of stroke | 13.0% (3) | 28.6% (10) | 0.17 |
- History of myocardial infarction | 21.7% (5) | 2.9% (1) | 0.02* |
- Smoking | 26.1% (6) | 0 | 0.001* |
Previous history of vertigo, % (n) | 13% (3) | 31.4% (11) | 0.11 |
Systolic BP, mmHg, med (IQR) | 161 (146–170) | 149 (139–168) | 0.10 |
Diastolic BP, mmHg, med (IQR) | 90 (75–100) | 80 (68–90) | 0.14 |
Pulse rate, bpm, med (IQR) | 80 (60–85) | 76 (70–82) | 0.87 |
Laboratory parameters | |||
- Hemoglobin, g/dL, med (IQR) | 13.7 (13.1–15.4) | 13.0 (12.5–13.4) | 0.009* |
- WBC count, *103/μL, mean (SD) | 9.91 (2.95) | 8.29 (2.21) | 0.03* |
- Platelets, *103/μ, mean (SD) | 227.61 (66.43) | 266.24 (81.14) | 0.07 |
- Creatinine, mg/dL, med (IQR) | 0.84 (0.71–0.98) | 0.67 (0.61–0.82) | 0.04* |
- Fasting blood sugar, mg/dL, med (IQR) | 130.0 (103–154) | 100.0 (80–113.5) | 0.008* |
- HbA1C, %, med (IQR) | 6.3 (5.6–7.2) | 5.6 (5.28–6.2) | 0.02* |
Medication, n(%) | |||
- Antiplatelets | 17.4% (4) | 37.1% (13) | 0.11 |
- Anticoagulant | 0% (0) | 2.9% (1) | 0.31 |